INMED Andes is implementing BilikitTM

Did you know that severe neonatal jaundice is the most common condition requiring medical treatment in newborns? Left untreated, it can lead to permanent brain damage and even death. In Peru, the rate of severe neonatal jaundice is 20 times greater than higher-income countries. To address this public health problem, INMED Andes is implementing the BilikitTM, a revolutionary trio of technologies to equip healthcare providers and community health workers to easily screen, diagnose and treat neonatal jaundice—even in the most remote regions. Learn more about this game-changing project for neonatal healthcare: